Original Publication Date: 1 November, 2014
Publication / Source: Future Oncology
Authors: Palma Fedele, Laura Orlando, Paola Schiavone, Annamaria Quaranta, Assunta Maria Lapolla, Maria De Pasquale, Antonino Ardizzone, Emilio Bria, Isabella Sperduti, Nicola Calvani, Antonella Marino, Chiara Caliolo, Enrica Mazzoni & Saverio Cinie
Aims: The prognostic role of BMI variation during and/or after treatments for early-stage breast cancer is still unknown. Patients & methods: The χ2 test was conducted to explore the correlation between breast cancer recurrence and BMI changes in 520 early-stage breast cancer patients. Cox proportional hazard models were used to analyze the association of BMI changes, baseline BMI, known prognostic factors and recurrences. Results: BMI gain was significant determinant of recurrences (p = 0.0008).